Search Results - "CHERBAVAZ, Diana B"
-
1
A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling
Published in European urology (01-09-2014)“…Abstract Background Prostate tumor heterogeneity and biopsy undersampling pose challenges to accurate, individualized risk assessment for men with localized…”
Get full text
Journal Article -
2
The 21-gene Recurrence Score® assay predicts distant recurrence in lymph node-positive, hormone receptor-positive, breast cancer patients treated with adjuvant sequential epirubicin- and docetaxel-based or epirubicin-based chemotherapy (PACS-01 trial)
Published in BMC cancer (04-05-2018)“…The 21-gene Recurrence Score (RS) result predicts outcome and chemotherapy benefit in node-negative and node-positive (N+), estrogen receptor-positive (ER+)…”
Get full text
Journal Article -
3
Characterization and functionality of proliferative human Sertoli cells
Published in Cell transplantation (01-06-2011)“…It has long been thought that mammalian Sertoli cells are terminally differentiated and nondividing postpuberty. For most previous in vitro studies immature…”
Get full text
Journal Article -
4
Analytical validation of the Oncotype DX prostate cancer assay - a clinical RT-PCR assay optimized for prostate needle biopsies
Published in BMC genomics (08-10-2013)“…The Oncotype DX Prostate Cancer Assay is a multi-gene RT-PCR expression assay that was developed for use with fixed paraffin-embedded (FPE) diagnostic prostate…”
Get full text
Journal Article -
5
Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study
Published in Breast cancer research and treatment (01-01-2019)“…Purpose The Recurrence Score test is validated to predict benefit of adjuvant chemotherapy. TransNEOS, a translational study of New Primary Endocrine-therapy…”
Get full text
Journal Article -
6
A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone
Published in Breast cancer research and treatment (01-07-2015)“…Validated biomarkers are needed to improve risk assessment and treatment decision-making for women with ductal carcinoma in situ (DCIS) of the breast. The Onco…”
Get full text
Journal Article -
7
21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy
Published in JNCI : Journal of the National Cancer Institute (01-01-2017)“…The 21-gene recurrence score (RS) predicts risk of locoregional recurrence (LRR) in node-negative, estrogen receptor (ER)-positive breast cancer. We evaluated…”
Get full text
Journal Article -
8
Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ
Published in JNCI : Journal of the National Cancer Institute (01-04-2017)“…Most women with ductal carcinoma in situ (DCIS) will receive breast-conserving surgery (BCS) and radiation (RT). RT can be omitted for women at low risk of…”
Get full text
Journal Article -
9
A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast
Published in JNCI : Journal of the National Cancer Institute (15-05-2013)“…For women with ductal carcinoma in situ (DCIS) of the breast, the risk of developing an ipsilateral breast event (IBE; defined as local recurrence of DCIS or…”
Get full text
Journal Article -
10
21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology
Published in Breast cancer research and treatment (01-02-2018)“…Background The 21-gene recurrence score (RS) predicts outcome and benefit from adjuvant chemotherapy benefit in breast cancer patients treated with adjuvant…”
Get full text
Journal Article -
11
A Prospective Comparison of the 21-Gene Recurrence Score and the PAM50-Based Prosigna in Estrogen Receptor-Positive Early-Stage Breast Cancer
Published in Advances in therapy (01-12-2015)“…Introduction The 21-gene Recurrence Score ® assay (Onco type DX ® , Genomic Health, Inc.) is a validated predictor of recurrence risk/chemotherapy benefit in…”
Get full text
Journal Article -
12
Gene expression in normal-appearing tissue adjacent to prostate cancers are predictive of clinical outcome: evidence for a biologically meaningful field effect
Published in Oncotarget (07-06-2016)“…We evaluated gene expression in histologically normal-appearing tissue (NT) adjacent to prostate tumor in radical prostatectomy specimens, assessing for…”
Get full text
Journal Article -
13
Metal Coordination-Based Inhibitors of Adenylyl Cyclase: Novel Potent P-Site Antagonists
Published in Journal of medicinal chemistry (22-05-2003)“…The adenylyl cyclases (ACs) are a family of intracellular enzymes associated with signal transduction by virtue of their ability to convert ATP to cAMP. The…”
Get full text
Journal Article -
14
Access to Phosphorylation in Isocitrate Dehydrogenase May Occur by Domain Shifting
Published in Biochemistry (Easton) (11-11-1997)“…To clarify further the mechanism of regulation by phosphorylation of isocitrate dehydrogenase, cocrystallization of isocitrate dehydrogenase and isocitrate…”
Get full text
Journal Article -
15
Agonist-induced calcium response in single human platelets assayed in a microfluidic device
Published in Analytical biochemistry (15-06-2005)“…To facilitate drug discovery directed toward platelet-specific targets, we developed a platelet isolation and fluorophore-loading method that yields…”
Get full text
Journal Article -
16
Discovery of ADDL--targeting small molecule drugs for Alzheimer's disease
Published in Current Alzheimer research (01-12-2007)“…Amyloid beta-derived diffusible ligands (ADDLs) comprise the neurotoxic subset of soluble Abeta(1-42) oligomers, now widely considered to be the molecular…”
Get more information
Journal Article -
17
Hydroxamate based inhibitors of adenylyl cyclase. Part 1: The effect of acyclic linkers on P-site binding
Published in Bioorganic & medicinal chemistry letters (04-11-2002)“…The adenylyl cyclases (ACs) are a family of enzymes that are key elements of signal transduction by virtue of their ability to convert ATP to cAMP. The…”
Get full text
Journal Article -
18
-
19
A pilot laboratory study comparing the 21-gene assay and PAM50-ROR
Published in Journal of clinical oncology (20-05-2014)“…Abstract only…”
Get full text
Journal Article -
20
The development of the DCIS score: Scaling and normalization in the Marin General Hospital cohort
Published in Journal of clinical oncology (20-09-2012)“…Abstract only 190 Background: In selected low-risk patients with DCIS treated with wide local excision without radiation, the DCIS score was validated as a…”
Get full text
Journal Article